Active Pharmaceutical Ingredient: Somatropin
Pack: 36 IU x 3 Mg/IU
Form:Injection
In the treatment of short children with growth retardation caused by lack or lack of growth hormone secretion
Treatment of growth retardation (Turner syndrome) in girls with gonadal dysgenesis (sexual differentiation disorder) confirmed by chromosome analysis
Treatment of growth retardation caused by chronic renal failure in children before puberty
In the treatment of growth disorder in short-born children younger than 4 weeks of age who did not catch growth by age 4 or older
Adults:
Treatment of significant growth hormone deficiency (GHD)
In adults who have been diagnosed with medically apparent growth hormone deficiency by means of a test, this treatment is applied.
General | |
Active Substance | Somatropin |
Form | Injection |